About Microbial Insights
Microbial Insights is a Healthcare company based in Knoxville (United States) founded in 1992. Microbial testing and analytical services are provided for environmental analysis. Microbial Insights offers products and services including ER Census® (qPCR), Bio-Trap® Samplers, and ER QuantArray®. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include Evelo Biosciences, Pendulum and PathogenDX; 3 of its 3 listed competitors have raised funding.
Company details
Microbial Insights was founded in 1992 in Knoxville, United States, and operates in the environmental microbiology sector. Analytical services are delivered for environmental remediation, microbe-induced corrosion assessment, and microbial source tracking. Techniques employed include microarrays, isotope analysis, next-generation sequencing, and stable isotope probing. These services support various industrial and research applications in microbial diagnostics.
- Headquarters Knoxville, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website microbe.com
- Social LinkedIn X Facebook
- Latest Funding Round$500K (USD), Grant
Mar 2011
- Investors
Products & Services of Microbial Insights
Microbial Insights offers a comprehensive portfolio of products and services, including ER Census® (qPCR), Bio-Trap® Samplers, and ER QuantArray®.
Quantitative PCR for environmental contaminant detection
Tools for in situ microbial community sampling
Advanced array for microbial quantification in remediation
Funding Insights of Microbial Insights
- Total Rounds 2
- Last Round Grant — $499,999
- First Round $100,000
(Jun 2009)
- Investors Count 1
All 2 funding rounds of Microbial Insights with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2011 | $499,999 | Grant | – | – | |
| Jun 2009 | $100,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Microbial Insights
Microbial Insights has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Microbial Insights
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Microbial Insights
7 people are tracked at Microbial Insights (6 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Sam Rosolina | VP, Applied Innovation | Leadership |
John Gallagher | VP, Business Development | Leadership |
Dora Taggart | CEO | Leadership |
Aj Hessock | Customer Service Director | Leadership |
Vlad Bobrek | Senior Vice President | Leadership |
Christian Polanco | Director Project Management | Leadership |
Hannah Ward | Project Management | Team |
Complete people profiles for Microbial Insights
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Microbial Insights
3 dated milestones of Microbial Insights across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Microbial Insights is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Grant, of $500K.
Competitors of Microbial Insights
Microbial Insights has 3 listed competitors in our database, 3 of them funded. They include Evelo Biosciences, Pendulum and PathogenDX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| pendulumlife.com | 2012 | San Francisco, United States | $109.5M | 55 | Pendulum is focused on developing advanced probiotic solutions. | |
| pathogendx.com | 2014 | Tucson, United States | $11.58M | 31 | Provider of DNA-based pathogen testing kits |
Detailed competitors of Microbial Insights
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Microbial Insights
The website of Microbial Insights (microbe.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 38.3% vs previous month
Websites whose visitors overlap most with Microbial Insights. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pathcon.com | 100% | View details | |||
casp-products.com | casp-products.com | 100% | – | ||
toxicmoldlab.com | toxicmoldlab.com | 100% | – | ||
elutrasep.com | elutrasep.com | 100% | – | ||
| sourcemolecular.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Microbial Insights
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Microbial Insights (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Microbial Insights
Microbial Insights was founded in 1992 and raised its 1st funding round 17 years after it was founded.
Microbial Insights is headquartered in Knoxville, United States. It is registered at Knoxville, Tennessee, United States.
Microbial Insights was founded in 1992 in Knoxville, United States, and operates in the environmental microbiology sector. Analytical services are delivered for environmental remediation, microbe-induced corrosion assessment, and microbial source tracking. Techniques employed include microarrays, isotope analysis, next-generation sequencing, and stable isotope probing. These services support various industrial and research applications in microbial diagnostics.
Microbial Insights's top competitors include Pendulum, PathogenDX and Evelo Biosciences.
Microbial Insights offers ER Census® (qPCR), Bio-Trap® Samplers, and ER QuantArray®.
Microbial Insights has 1 investor. Key investors include National Science Foundation.